Abstract:Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent chronic liver diseases worldwide with an unclear mechanism. Long non-coding RNAs (lncRNAs) have recently emerged as important regulatory molecules. To better understand NAFLD pathogenesis, lncRNA and messenger RNA (mRNA) microarrays were conducted in an NAFLD rodent model. Potential target genes of significantly changed lncRNA were predicted using cis/trans-regulatory algorithms. Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were then performed to explore their function. In the current analysis, 89 upregulated and 177 downregulated mRNAs were identified, together with 291 deregulated lncRNAs. Bioinformatic analysis of these RNAs has categorized these RNAs into pathways including arachidonic acid metabolism, circadian rhythm, linoleic acid metabolism, peroxisome proliferator-activated receptor (PPAR) signaling pathway, sphingolipid metabolism, steroid biosynthesis, tryptophan metabolism and tyrosine metabolism were compromised. Quantitative polymerase chain reaction (qPCR) of representative nine mRNAs and eight lncRNAs (named fatty liver-related lncRNA, FLRL) was conducted and this verified previous microarray results. Several lncRNAs, such as FLRL1, FLRL6 and FLRL2 demonstrated to be involved in circadian rhythm targeting period circadian clock 3 (Per3), Per2 and aryl hydrocarbon receptor nuclear translocator-like (Arntl), respectively. While FLRL8, FLRL3 and FLRL7 showed a potential role in PPAR signaling pathway through interaction with fatty acid binding protein 5 (Fabp5), lipoprotein lipase (Lpl) and fatty acid desaturase 2 (Fads2). Functional experiments showed that interfering of lncRNA FLRL2 expression affected the expression of predicted target, circadian rhythm gene Arntl. Moreover, both FLRL2 and Arntl were downregulated in the NAFLD cellular model. The current study identified lncRNA and corresponding mRNA in NAFLD, providing new insight into the pathogenesis of NAFLD. Moreover, we identified a new lncRNA FLRL2, that might participate NAFLD pathogenesis mediated by Arntl.

Noncoding RNAs in Alcoholic Liver Disease

Analysis of Differentially Expressed Genes and Micrornas in Alcoholic Liver Disease

Pattern of Microrna Expression Associated with Different Stages of Alcoholic Liver Disease in Rat Models

Deciphering the role of LncRNA in alcoholic liver disease: Mechanisms and therapeutic potential

miRNAs in patients with alcoholic liver disease: a systematic review and meta-analysis

Circulating MicroRNAs As Potential Biomarkers for Alcoholic Steatohepatitis.

Long Non-Coding Rna Profiling In A Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight Into Pathogenesis

LncRNA and circRNA in Patients with Non-Alcoholic Fatty Liver Disease: A Systematic Review

Long Non-Coding RNA CRNDE As Potential Biomarkers Facilitate Inflammation and Apoptosis in Alcoholic Liver Disease.

Role of Noncoding RNA in Development of Nonalcoholic Fatty Liver Disease

Identifying competing endogenous RNA regulatory networks and hub genes in alcoholic liver disease for early diagnosis and potential therapeutic target insights

Circulating miRNAs as Novel Diagnostic Biomarkers in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Role of noncoding RNAs in liver fibrosis

Non-coding RNA in Alcohol Use Disorder by Affecting Synaptic Plasticity

Long Non-Coding RNAs in Non-Alcoholic Fatty Liver Disease; Friends or Foes?

Alcohol and the mechanisms of liver disease

Altered Regulation of LncRNA Analysis of Human Alcoholic Hepatitis with Mallory-Denk Bodies (mdbs) is Revealed by RNA Sequencing.

Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease

Myeloid Cells in Alcoholic Liver Diseases: Mechanism and Prospect

LncRNA H19 promoted alcohol-associated liver disease through dysregulation of alternative splicing and methionine metabolism

Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease